Her son had been sick for four months when Blanca Morales started asking about a transplant. It had started with a case of ...
A vaccine reduced the risk of developing Lyme disease by more than 70%, according to the drugmaker Pfizer and Valneva, who are developing it. Though results appear to have missed a key statistical bar ...
An experimental treatment for eczema from Apogee Therapeutics induced skin and itch relief comparable to current, widely used ...
The decline of trust in health care in the U.S. has been ongoing and was worsened by the institutional responses to the Covid-19 pandemic. A national survey of more than 443,000 U ...
A nationwide STAT survey of NIH-funded researchers reveals that, a year after Donald Trump's return to the White House, many ...
The Trump administration is weighing how to respond to a court ruling on vaccine policymaking, a decision that could come ...
The CDC had remarkable data on smoking rates last fall, but it no longer had smoking experts available to review it and ...
In Massachusetts, sepsis cases has more than tripled since 2010. Some blame hospitals' use of AI tools for medical coding and ...
Chris Klomp, a top official at the federal health department, offered a reality check on President Trump’s drug discount ...
Today's biotech news includes the Medicare director offering a tempered view of TrumpRx and high-dose Wegovy getting an FDA ...
A group of autism scientists kicked off efforts Thursday to influence Congress, and the research agendas of private ...
Following successful appeals from drugmakers, the U.K. is taking another look at whether two new Alzheimer's drugs can be ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results